05:08 PM EDT, 07/31/2025 (MT Newswires) -- Corcept Therapeutics ( CORT ) reported fiscal Q2 net income late Thursday of $0.29 per diluted share, down from $0.32 a year ago.

Analysts polled by FactSet expected $0.19.

Revenue for the quarter ended June 30 was $194.4 million, up from $163.8 million a year earlier.

Analysts expected $199.4 million.